Literature DB >> 21149325

Linking epidemiology to epigenomics--where are we today?

Cornelia M Ulrich1, William M Grady.   

Abstract

Cancer is the consequence of genetic and epigenetic alterations. Genetic mutations likely result in part from exposure to environmental carcinogens, giving rise to a large field of cancer-prevention study of these carcinogens and ways to develop strategies to avoid them. Our understanding of regulatory epigenetic mechanisms associated with DNA methylation, histone modifications, and microRNA production is increasing rapidly. The involvement of these processes in carcinogenesis raises the possibility that environmental exposures may promote or prevent cancer through affecting the epigenome. Modifying the epigenome to prevent cancer is particularly intriguing because epigenetic alterations are potentially reversible, unlike gene mutations, and because certain dietary factors, such as the B-vitamin folate, may affect genes' DNA methylation status (as reported by Wallace et al., beginning on page 1552 in this issue of the journal). Rapidly improving techniques for assessing epigenetic alterations promise to yield important insights for cancer prevention. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 21149325      PMCID: PMC3048787          DOI: 10.1158/1940-6207.CAPR-10-0298

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  35 in total

1.  Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene.

Authors:  L L Stern; J B Mason; J Selhub; S W Choi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-08       Impact factor: 4.254

2.  Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

Authors:  Steven A Belinsky; William A Palmisano; Frank D Gilliland; Lida A Crooks; Kevin K Divine; Sally A Winters; Marcie J Grimes; Heidi J Harms; Carmen S Tellez; Tammy M Smith; Pam P Moots; John F Lechner; Christine A Stidley; Richard E Crowell
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

3.  Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.

Authors:  Kristin Wallace; Maria V Grau; A Joan Levine; Lanlan Shen; Randala Hamdan; Xinli Chen; Jiang Gui; Robert W Haile; Elizabeth L Barry; Dennis Ahnen; Gail McKeown-Eyssen; John A Baron; Jean Pierre J Issa
Journal:  Cancer Prev Res (Phila)       Date:  2010-12

4.  DNA methylation and environmental exposures in human hepatocellular carcinoma.

Authors:  Lanlan Shen; Nita Ahuja; Yu Shen; Nagy A Habib; Minoru Toyota; Asif Rashid; Jean-Pierre J Issa
Journal:  J Natl Cancer Inst       Date:  2002-05-15       Impact factor: 13.506

5.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.

Authors:  Duk-Hwan Kim; Jin Seuk Kim; Yong-Ick Ji; Young Mog Shim; Hojoong Kim; Joungho Han; Joobae Park
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

7.  Transposable elements: targets for early nutritional effects on epigenetic gene regulation.

Authors:  Robert A Waterland; Randy L Jirtle
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  Methylenetetrahydrofolate reductase 677C-->T polymorphism affects DNA methylation in response to controlled folate intake in young women.

Authors:  Karla P Shelnutt; Gail P A Kauwell; Jesse F Gregory; David R Maneval; Eoin P Quinlivan; Douglas W Theriaque; George N Henderson; Lynn B Bailey
Journal:  J Nutr Biochem       Date:  2004-09       Impact factor: 6.048

Review 9.  Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies.

Authors:  Young-In Kim
Journal:  Environ Mol Mutagen       Date:  2004       Impact factor: 3.216

10.  Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma.

Authors:  Steven A Belinsky; Donna M Klinge; Kieu C Liechty; Thomas H March; Terri Kang; Frank D Gilliland; Natalie Sotnic; Galina Adamova; Galina Rusinova; Vitaliy Telnov
Journal:  Carcinogenesis       Date:  2004-01-23       Impact factor: 4.944

View more
  6 in total

1.  Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women.

Authors:  Cornelia M Ulrich; Adetunji T Toriola; Lisel M Koepl; Tracy Sandifer; Elizabeth M Poole; Catherine Duggan; Anne McTiernan; Jean-Pierre J Issa
Journal:  Epigenetics       Date:  2012-08-07       Impact factor: 4.528

2.  Genome-Wide Epigenetic Studies in Human Disease: A Primer on -Omic Technologies.

Authors:  Huihuang Yan; Shulan Tian; Susan L Slager; Zhifu Sun; Tamas Ordog
Journal:  Am J Epidemiol       Date:  2015-12-30       Impact factor: 4.897

3.  The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study.

Authors:  Xinran Xu; Marilie D Gammon; Elizabeth Jefferson; Yujing Zhang; Yoon Hee Cho; James G Wetmur; Susan L Teitelbaum; Patrick T Bradshaw; Mary Beth Terry; Gail Garbowski; Hanina Hibshoosh; Alfred I Neugut; Regina M Santella; Jia Chen
Journal:  Epigenetics       Date:  2011-11-01       Impact factor: 4.528

4.  Global DNA Methylation, Measured by the Luminometric Methylation Assay (LUMA), Associates with Postmenopausal Breast Cancer in Non-Obese and Physically Active Women.

Authors:  Lauren E McCullough; Jia Chen; Alexandra J White; Xinran Xu; Yoon Hee Cho; Patrick T Bradshaw; Sybil M Eng; Susan L Teitelbaum; Mary Beth Terry; Gail Garbowski; Alfred I Neugut; Hanina Hibshoosh; Regina M Santella; Marilie D Gammon
Journal:  J Cancer       Date:  2015-05-01       Impact factor: 4.207

5.  The role of micronutrients in the risk of urinary tract cancer.

Authors:  Tomasz Golabek; Jakub Bukowczan; Robert Sobczynski; Jaroslaw Leszczyszyn; Piotr L Chlosta
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

6.  The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.

Authors:  Daisuke Kawakita; Yuan-Chin Amy Lee; Lisa H Gren; Saundra S Buys; Carlo La Vecchia; Mia Hashibe
Journal:  Br J Cancer       Date:  2017-11-21       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.